This company listing is no longer active
InVision Past Earnings Performance
Past criteria checks 0/6
InVision's earnings have been declining at an average annual rate of -60.1%, while the Software industry saw earnings growing at 15.7% annually. Revenues have been growing at an average rate of 3.5% per year.
Key information
-60.1%
Earnings growth rate
-63.7%
EPS growth rate
| Software Industry Growth | 14.9% |
| Revenue growth rate | 3.5% |
| Return on equity | -48.7% |
| Net Margin | -19.4% |
| Last Earnings Update | 30 Sep 2023 |
Recent past performance updates
Recent updates
Is InVision (ETR:IVX) Using Too Much Debt?
Oct 26
InVision Aktiengesellschaft (ETR:IVX) Soars 35% But It's A Story Of Risk Vs Reward
Aug 31Is InVision (ETR:IVX) Using Too Much Debt?
Jul 22Should You Think About Buying InVision Aktiengesellschaft (ETR:IVX) Now?
May 18InVision (ETR:IVX) Has Debt But No Earnings; Should You Worry?
Mar 16Health Check: How Prudently Does InVision (ETR:IVX) Use Debt?
Jul 06Here's Why We Think InVision Aktiengesellschaft's (ETR:IVX) CEO Compensation Looks Fair for the time being
Sep 30Is InVision (ETR:IVX) Using Too Much Debt?
Sep 01It's Unlikely That InVision Aktiengesellschaft's (ETR:IVX) CEO Will See A Huge Pay Rise This Year
May 20InVision (ETR:IVX) Could Easily Take On More Debt
May 04InVision Aktiengesellschaft Just Missed EPS By 37%: Here's What Analysts Think Will Happen Next
Mar 28Does InVision (ETR:IVX) Deserve A Spot On Your Watchlist?
Mar 15Will InVision (ETR:IVX) Multiply In Value Going Forward?
Feb 25InVision Aktiengesellschaft's (ETR:IVX) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
Feb 08
Is InVision Aktiengesellschaft (ETR:IVX) Potentially Undervalued?
Jan 23These 4 Measures Indicate That InVision (ETR:IVX) Is Using Debt Safely
Jan 05InVision (ETR:IVX) Is Growing Earnings But Are They A Good Guide?
Dec 03What Do The Returns On Capital At InVision (ETR:IVX) Tell Us?
Nov 19Revenue & Expenses Breakdown
How InVision makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 23 | 15 | -3 | 0 | 0 |
| 30 Jun 23 | 15 | -3 | 0 | 0 |
| 31 Mar 23 | 15 | -4 | 0 | 0 |
| 31 Dec 22 | 14 | -4 | 0 | 0 |
| 30 Sep 22 | 14 | -3 | 0 | 0 |
| 30 Jun 22 | 14 | -3 | 0 | 0 |
| 31 Mar 22 | 14 | -2 | 0 | 0 |
| 31 Dec 21 | 14 | -2 | 0 | 0 |
| 30 Sep 21 | 13 | -1 | 0 | 0 |
| 30 Jun 21 | 13 | 0 | 0 | 0 |
| 31 Mar 21 | 13 | 0 | 0 | 0 |
| 31 Dec 20 | 13 | 0 | 0 | 0 |
| 30 Sep 20 | 13 | 3 | 1 | 0 |
| 30 Jun 20 | 12 | 3 | 1 | 0 |
| 31 Mar 20 | 13 | 3 | 1 | 0 |
| 31 Dec 19 | 13 | 3 | 1 | 0 |
| 30 Sep 19 | 13 | 0 | 1 | 0 |
| 30 Jun 19 | 13 | 0 | 1 | 0 |
| 31 Mar 19 | 13 | 0 | 1 | 0 |
| 31 Dec 18 | 13 | 0 | 1 | 0 |
| 30 Sep 18 | 13 | 0 | 1 | 0 |
| 30 Jun 18 | 13 | 0 | 1 | 0 |
| 31 Mar 18 | 13 | 0 | 1 | 0 |
| 31 Dec 17 | 13 | 1 | 1 | 0 |
| 30 Sep 17 | 13 | 2 | 1 | 0 |
| 30 Jun 17 | 13 | 1 | 1 | 0 |
| 31 Mar 17 | 13 | 2 | 1 | 0 |
| 31 Dec 16 | 12 | 2 | 1 | 0 |
| 30 Sep 16 | 13 | 2 | 1 | 0 |
| 30 Jun 16 | 13 | 3 | 1 | 0 |
| 31 Mar 16 | 13 | 2 | 1 | 0 |
| 31 Dec 15 | 13 | 2 | 1 | 0 |
| 30 Sep 15 | 13 | 3 | 1 | 0 |
| 30 Jun 15 | 13 | 3 | 1 | 0 |
| 31 Mar 15 | 13 | 4 | 1 | 0 |
| 31 Dec 14 | 13 | 4 | 1 | 0 |
| 30 Sep 14 | 13 | 4 | 0 | 0 |
| 30 Jun 14 | 13 | 3 | 0 | 0 |
| 31 Mar 14 | 14 | 2 | 0 | 0 |
| 31 Dec 13 | 14 | 2 | 0 | 0 |
| 30 Sep 13 | 13 | 2 | 0 | 0 |
| 30 Jun 13 | 13 | 1 | 0 | 0 |
Quality Earnings: IVX is currently unprofitable.
Growing Profit Margin: IVX is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: IVX is unprofitable, and losses have increased over the past 5 years at a rate of 60.1% per year.
Accelerating Growth: Unable to compare IVX's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: IVX is unprofitable, making it difficult to compare its past year earnings growth to the Software industry (7.1%).
Return on Equity
High ROE: IVX has a negative Return on Equity (-48.71%), as it is currently unprofitable.